Tandem Diabetes Care (MEX:TNDM) Total Equity: MXN2,388 Mil (As of Mar. 2026)


MEX:TNDM Tandem Diabetes Care Inc MEX:TNDM
66 GF Score
Price MXN745.00
GF Value MXN1,446.01
! 5 Warning Signs
View Full Analysis

What is Tandem Diabetes Care Total Equity?

Tandem Diabetes Care MEX:TNDM 66 Total Equity is MXN2,388 Mil as of Mar. 2026. GuruFocus rates MEX:TNDM with a GF Score™ of 66/100 and a GF Value™ of MXN1,446.01. The stock has 5 warning signs investors should review.

Tandem Diabetes Care's total equity for the quarter that ended in Mar. 2026 was MXN2,388 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Tandem Diabetes Care Total Equity Historical Data

* Premium members only.

The historical data trend for Tandem Diabetes Care's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tandem Diabetes Care Total Equity Chart

Tandem Diabetes Care Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,884.86 8,577.21 5,323.67 5,487.09 2,793.94

Tandem Diabetes Care Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,177.00 2,509.61 2,439.14 2,793.94 2,387.58
MEX:TNDM
66GF Score
Tandem Diabetes Care Inc MEX:TNDM
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tandem Diabetes Care Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Tandem Diabetes Care's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=15865.038-13071.094
=2,794

Tandem Diabetes Care's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=20798.808-18411.224
=2,388

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of MXN2,388 Mil mean?
Tandem Diabetes Care (MEX:TNDM) has a Total Equity of MXN2,388 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Tandem Diabetes Care and its competitors.
Is Tandem Diabetes Care's Total Equity too high?
Tandem Diabetes Care's current Total Equity is MXN2,388 Mil. Overall, Tandem Diabetes Care has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Tandem Diabetes Care's Total Equity compare to CNMD and AORT?
Tandem Diabetes Care's Total Equity of MXN2,388 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Tandem Diabetes Care and its competitors. Tandem Diabetes Care's current Total Equity is MXN2,388 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tandem Diabetes Care stock overvalued right now?
Tandem Diabetes Care (MEX:TNDM) has a current Total Equity of MXN2,388 Mil. The stock's GF Value™ is MXN1,446.01, compared to a current price of MXN745.00 — trading 48.5% below its estimated fair value. The current Total Equity is MXN2,388 Mil. Tandem Diabetes Care's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Tandem Diabetes Care (MEX:TNDM), the current Total Equity is MXN2,388 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tandem Diabetes Care (MEX:TNDM) Overvalued in 2026?

Based on GuruFocus' analysis, Tandem Diabetes Care stock appears to be undervalued. The current stock price of MXN745.00 is trading 48.5% below its estimated GF Value™ of MXN1,446.01.

Key valuation signals for MEX:TNDM:

  • Total Equity: MXN2,388 Mil
  • GF Value™: MXN1,446.01 vs. price of MXN745.00 (48.5% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the MEX:TNDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tandem Diabetes Care Business Description

Address 12400 High Bluff Drive, San Diego, CA, USA, 92130
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
66GF Score

Get the complete analysis for MEX:TNDM

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN745.00
Price
MXN1,446.01
GF Value